KENDRA K. BENCE

Senior Director, Metabolism
Pfizer
New Zealand

Scientist Toxicology
Biography

 Kendra Bence, PhD, is Senior Director of Metabolism, heading up research and discovery efforts in the type II diabetes and Non-Alcoholic Fatty Liver Disease/Non-alcoholic steatohepatitis therapeutic areas for the Pfizer Cardiovascular and Metabolic Research Unit. Dr. Bence leads a talented team of scientists focused on developing a deep understanding of the intricate biological mechanisms underlying type II diabetes and fatty liver disease, with the goal of identifying novel ways to treat and eventually prevent these metabolic diseases. She is also the Cardiovascular and Metabolic representative to the Pfizer WRD Post-Doctoral Program and has a strong commitment to training and mentoring the next generation of scientists.

Research Intrest

 Cardiology